Local Anesthetic Market

Key data points: Market size in 2027 = $5.6 billion and 2035 = $7.3 billion, growth forecast = 3.4% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in local anesthetic market to 2035 by type (esters and amides), application (hospital and clinic), and region (North America, Europe, Asia Pacific, and the Rest of the World) Local Anesthetic Market The future of the global local anesthetic market looks promising with opportunities in the hospital and clinic markets. The global local anesthetic market is expected to reach an estimated $7.3 billion by 2035 from $5.6 billion in 2027 with a CAGR of 3.4% from 2027 to 2035. The major drivers for this market are the increasing volume of surgical procedures, the rising demand for pain management solutions, and the growing use in outpatient medical settings. • Lucintel forecasts that, within the type category, amides is expected to witness higher growth over the forecast period due to more stability and less allergenicity of amides. • Within the application category, hospital is expected to witness higher growth over the forecast period due to more surgical and dental procedures done in hospitals. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to more surgical procedures and further development of health care structures and systems. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Local Anesthetic Market The focus of the livestock vaccine market will be on preventing and controlling diseases through surveillance and other strategies from 2025 to 2027. Lucintel also anticipates positive growth in the veterinary biologics market. Customers are seeking vaccines that reduce the use of antibiotics, and vaccines that integrate with other activities to accomplish effective disease control. • Preventive Health Management: Anticipating that the use of vaccination to control and prevent animal diseases will continue. Several countries in the region are further developing prevention programs against Avian and Swine Flu, as well as Foot and Mouth diseases. • Vaccine Innovation: Further improvements to the cold chain will allow vaccines to be stored at higher temperatures. Recently, thermostable vaccines have gained attention. Improving the cold chain will allow vaccines to be administered to animals in remote areas. • Digital Disease Surveillance: The use of diagnostics to identify diseases has increased. Real time PCRs and other sequencing technologies to detect trans-boundary animal diseases have increased. Other mobile and digital technologies will increase and improve the surveillance of vaccination programs and other prevention activities. • Platforms and Combination Vaccines: Expect growth in the next few years of products that incorporate multiple vaccines, addressing more than one disease with a single dose. These products will also decrease the development time of vaccines that cover diseases that occur in different parts of the world. • Regional Manufacturing: A focus will also be on building regional vaccine and animal health product manufacturing. Supply disruptions due to the COVID-19 pandemic and other reasons increased the need to reduce reliance on a few manufacturing locations. Of note are the recent and ongoing efforts and investments by countries in Africa and India. While vaccine sales will be stagnant, the industry will benefit from other downstream and auxiliary product and service offerings. The greatest opportunities will be in high potential, underdeveloped, livestock rich countries, in which the productivity gap is greatest, and where investment in the transport and distribution infrastructure will be focused in the next five to ten years. Recent Developments in the Local Anesthetic Market There is growing demand for local anesthetics as the focus on perioperative opioid reduction and around-the-clock pain management has intensified. It is expected that from 2025 to 2027, the market will see the introduction of several new products based on different pain pathways as compared to the traditional injectable products. Lucintel is of the view that the pain management market will show positive growth and propel the related investments in this sector. However, the reimbursement scenarios will largely govern the market growth. • The Introduction of Non-opioid Products: The FDA’s approval of suzetrigine for the management of acute pain in 2025 created a new product category and competition for local anesthetics for the acute pain market. Local anesthetic suppliers may need to establish evidence on improved outcomes and recovery as compared to suzetrigine in the next 3 to 5 years to remain competitive in this space. • Long Acting Products: One of the recent innovations in the pain management space has been the use of liposomal bupivacaine. This has the potential to significantly reduce the nursing workload and drawdown time. Products like EXPAREL which provides 24-48 hours of analgesia, have the potential to help healthcare systems manage costs associated with long and complex procedures. • Increased Supply: Due to increased demand and repeated shortages of local anesthetics like bupivacaine, suppliers have started increasing their supply. In 2025, Fresenius Kabi increased their product portfolio by 20 locally administered anesthetics. The increased supply and competition is expected to lower prices of existing products. • Dental Channel: Increased digital education and product support for dental anesthetics and continued investment in cartridge manufacturing, Dental procedures remain a large, and growing, area of focus. Packaging, and product design, can impact the product decisions made by consolidating dental clinics. • Regulatory Environment: Raised the bar for comparative effectiveness for Journavx, but signaled growing market interest for non-opioid acute pain relief. The next 3-5 years will require the generation of comparative effectiveness data to support marketing claims for non-opioid pain relief. The difference will likely be made in terms of economics, e.g. reduced use of rescue medications and length of stay. Ensuring adequate supply will require further investment, but comparative effectiveness and production cost concerns will remain. From a competitive perspective, it will be required to leverage all three aspects of competition, particularly economics. The ability to integrate comparative effectiveness data that supports a claim of reduction in total cost of care, will likely result in improved product uptake. The same will apply to the production of data that supports a claim for a product that facilitates a reduction in the total care cost and the use of opioids. Capacity constraints, combined with an increased regulatory environment and price competition, will increase the premium on dependable, differentiated, and sterile product delivery systems in the hospital market. Strategic Growth Opportunities in the Local Anesthetic Market Market disruptions are creating opportunities for local anesthetic market growth. Risks in the supplier base and growing awareness of anesthetic safety will drive the local anesthetic market in the 2024-2026 time frame. Lucintel has identified five growth opportunities for local anesthetics. • Expansion of Extended-Release Bupivacaine Products: New bupivacaine products with extended release local anesthesia will offer healthcare providers the ability to manage pain for longer periods of time. The current products on the market have inspired the development of competitive products. New products that remain on the market for longer periods of time will displace the need for rescue opioids. • Growing Demand for Local Anesthetics in Outpatient Surgery: Increasing numbers of outpatient surgical procedures will create greater demand for local anesthetic products to manage pain and other symptoms during surgical procedures. It is expected that in 2025, approximately 25 million outpatient surgical procedures will occur in the U.S. Local anesthetic products that facilitate outpatient surgical procedures will impact a hospital’s bottom line. • Rising Demand for Aesthetic and Dental Anesthesia Products: Aesthetic and dental elective procedures, such as cosmetic surgery and dentistry, are on the rise. Faster onset and reduced volume products can be sold at higher margins and are in higher demand. As reported by Henry Schein, approximately $13.2 billion of dental products were sold in 2024. Products with improved formulations will succeed if clinicians believe that product handling and patient comfort affect the overall procedure. • Growth of Localized Injectable Manufacturing: Pharmaceutical companies have begun to establish local manufacturing and contract facilities in order to meet the demand for injectables. Manufacturing in these regions will help decrease the reliance on importing these products. From April-December of 2024, the pharmaceutical manufacturing sector of India achieved exports of $27.9 billion. These localized facilities will help gain contracts for the next several years. • Adoption of Digital and Technology-Enabled Anesthesia Solutions: Digital and technological solutions to improve safety and manage anesthesia will become commonplace. As of March 2025, there were 1,529 drug shortages reported by the FDA. Many of these shortages were anesthetics. As these and other technology solutions demonstrate improvement to clinical workflow and savings, they will become standard in clinical practice. Products that achieve improved duration and reduce exposure to opioids and other controlled substances will be ideal for ambulatory care and procedures. Proper regulation and formulation will allow manufacturers to achieve prices above average, while improving the overall clinical workflow. Clinical evidence and data to support product claim will be more valuable than having a large product catalog. Local Anesthetic Market Drivers and Challenges There are many trends that impact the local anesthetics market like the rate of medical innovation, changes in healthcare spending, the legislation surrounding medical practice and procedure volumes. The market is also impacted by evolving consumer expectations. There is a growing market need for rapid-acting, long-lasting and safe anesthetics. Market disruptions by new entrants will be driven by product innovations. Traditionally, the local anesthetics market has been dominated by a few large players. While this trend is expected to continue, the introduction of new products and greater access to medical care is expected to stimulate market growth. The local anesthetics market is still constrained by a number of factors including stiff price competition, side effects and stringent regulatory approval processes. The focus of market participants in the near term will be improving the safety and efficacy of anesthetics. The factors responsible for driving this market include: • Rising Need for Outpatient Surgical Procedures: Growing numbers of minimally invasive and cosmetic surgeries have increased the need for local anesthesia. In 2025, the World Health Organization (WHO) reported that many countries still lacked the essential surgical and anesthesia care services to address the health needs of the population. It is expected that the growing elderly and chronic health conditions populations will increase the demand for medical and surgical procedures, and consequently, the consumption of local and regional anesthetic products. • Improvements in Technology: New technology in anesthetic delivery can improve the comfort, and the duration of anesthesia. March 2025’s trends in regional anesthesia showed use of ultrasound for different nerve blocks in various specialties. Other emerging anesthetic technology may decrease the need for repeated doses of local anesthetic, and facilitate same day discharge from the hospital. • Regulatory and Clinical Changes: There is a growing trend in the use of regional anesthesia in conjunction with other (non-opioid) means of anesthesia and pain management. Changes in regulations may facilitate the use of different formulations of local anesthetic, including topical and spray formulations. The U.S. Food and Drug Administration (FDA) has also eased the approval process for alternative dosage forms of already-approved local anesthetics. Manufacturers may also need to invest in research for new formulations and ensure that the raw materials used are of consistent and good quality. • The Rise of Outpatient Care: There has been a greater focus in recent years on the use of local anesthesia in medical and dental practices. The use of local anesthesia in various outpatient surgeries, and the treatment of medical conditions has increased. There has been a growing interest in cost-efficiency in the healthcare industry of developed countries, particularly in reducing the length of stay in hospitals. Over the next three to five years, it is anticipated that even more procedures will be performed outside of hospitals. It is likely that there will be increased demand for quick-acting, and easy to use anesthetic products. • Product Innovation and Manufacturing Efficiency: Innovation in product development and manufacturing has resulted in preservative-free and combination products, as well as advanced forms of medication, such as longer-lasting injectables, and packaging that promotes user safety and reduces error. Of particular interest in clinical settings in 2025, were ready-to-use and single-dose formulations, for example, ready-to-use local anesthetics, as they simplify preparation and improve workspace flow. Within the next 3-5 years, the global market is expected to grow due to the development of various technologies that provide greater reliability in cold-chain shipping, and improve the automation of production and filling. The challenges facing this market include: • Safety and Side Effects: There are several side effects and safety risks associated with local anesthetics that can constrain their use. In 2025, numerous safety protocols were maintained to minimize the risks associated with regional anesthesia. Safety concerns related to the use of local anesthetics and the potential for health care personnel to err in administration will likely lead to increased demand for the improvement of local anesthetic formulations, standardized and safe procedures for their administration, and training of health care personnel. • Price and Supply: Variability in the price of raw materials, and raw material shortages, together with restricted reimbursements and generic competition, negatively impact profitability and availability of local anesthetics. In 2025, several hospitals restricted the local anesthetics in their formularies to essential medications. It was recognized that the unavailability of local anesthetics could impact a surgical procedure. • Stringent Regulatory Requirements: The expansion of routes of administration and the introduction of new delivery systems have posed greater challenges in the development of pharmaceutical products and required additional clinical studies, validation of the manufacturing process, and stability studies. These changes have increased the demand for post-market control of medicinal products. For example, in August 2025, the regulatory authorities requested additional documentation concerning the quality of medicinal products, particularly contamination control and acceptance of batches of pharmaceutical products. During the next 3 to 5 years, it is expected that greater requirements and stricter controls will be established for the approval of pharmaceutical products, especially for the smaller pharmaceutical companies. Even though this could lead to a decrease in the number of sub-standard and counterfeit products in the market, it will represent a greater obstacle for small pharmaceutical companies to develop and commercialize new products. Because of the growing need for outpatient surgeries and other procedures, the market for products that contain local anesthetics is expected to grow. Other factors that could also drive the local anesthetic market include the use of these products in procedures to replace the need for opioids and other narcotics, and the use of local anesthetics in dentistry. Factors that could limit the growth of the local anesthetic market include the presence of adverse effects and other risks associated with the use of local anesthetics and the introduction of products by multiple manufacturers. List of Local Anesthetic Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies local anesthetic market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the local anesthetic market companies profiled in this report include- • Septodont • Inibsa • AstraZeneca • Fresenius Kabi • Pfizer Local Anesthetic Market by Segment The study includes a forecast for the global local anesthetic market by type, application, and region. Local Anesthetic Market by Type [Value ($B) from 2019 to 2035]: • Esters • Amides Local Anesthetic Market by Application [Value ($B) from 2019 to 2035]: • Hospital • Clinic Local Anesthetic Market by Region [Value ($B) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Local Anesthetic Market Healthcare policy changes, localized drug manufacturing, and the opioid crisis are expected to impact the local anesthetics market between 2025 and 2027, according to Lucintel. Successful and innovative companies will dominate the health markets. • United States: New Product: In January 2025, Vertex received FDA approval to develop JOURNAVX, a non-opioid, acute pain medicine. Local anesthetics generally contain esthers. Because JOURNAVX is not a local anesthetic, it is not clear why Vertex gained approval to market the drug in 2025. The approval is expected to stimulate the creation of similar drugs and encouragement of local anesthetic medicines in combination with other pain management medicines. • China: New Facilities: In 2024, Fresenius Kabi (China) developed additional facilities to produce injectable anesthetics and analgesics. Additionally, the Chinese government extended its centralized drug procurement program, which covered 260 different medicines. Both of these occurrences are likely to create more competitive, locally produced, and reasonably priced anesthetic and analgesic medicines. • Germany: Investment: Pharmaceutical producer B. Braun expects to generate €9.1 billion in 2024 group sales. In 2023, the company started the construction of a European pharma production site. The German site will contribute to the local supply of injectables and will diminish the reliance on imported products. • India: Manufacturing and Exports: The Indian pharmaceutical industry exported $27.9 billion worth of products between April-December 2024. Several companies initiated the manufacture of complex injectables. With an adequate supply, prices are expected to fall thereby facilitating wider availability of generic lidocaine and bupivacaine. • Japan: Regulatory Framework and Product: Revisions to the guidelines of the Japanese Ministry of Health, Labor and Welfare (MHLW) 2025 are expected to promote the usage of more peri-operative pain-management drugs. Manufacturers focused on the production of traditional injectable anesthetics (lidocaine and ropivacaine). Given the above mentioned trends, it is expected that the Japanese market will continue its focus on safer regional anesthesia. Features of the Global Local Anesthetic Market Market Size Estimates: local anesthetic market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: local anesthetic market size by type, application, and region in terms of value ($B). Regional Analysis: local anesthetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the local anesthetic market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the local anesthetic market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the local anesthetic market by type (esters and amides), application (hospital and clinic), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?